Alogliptin And Pioglitazone + Rifampin Interaction
Moderateinteraction on record
Description
CYP2C8 inducer may significantly decrease pioglitazone exposure. Changes in diabetes treatment may be needed based on clinical response.
Mechanism
CYP2C8 induction decreases pioglitazone AUC
Source: NLP:alogliptin benzoate and pioglitazone hydrochloride